Sana Biotechnology

### Executive Summary Sana Biotechnology raised $511.4M in a Reg D private placement, signaling massive institutional appetite for synthetic biology and intracellular mRNA delivery. The first sale date of 2021-10-12 suggests this filing is an update or delayed notice, not a fresh round, but the capital raised is among the largest in the sector. ### Investor Edge Sophisticated investors should monitor whether this filing is a precursor to a confidential IPO filing or a large strategic partnership with a defense contractor, given Lockheed Martin Ventures involvement. ### Sector capital positioning This $511.4M raise reflects sustained high-yield private capital flowing into synthetic biology and mRNA delivery platforms, reinforcing the sector's momentum beyond the pandemic era. ### Convergence Signals No explicit public signals such as patents, contracts, or legislation are tied to this filing. However, the size and related persons (Lockheed Martin Ventures, Bessemer Venture Partners) hint at potential defense/biotech crossover or strategic partnerships that remain unconfirmed. ### Key Takeaways - $511.4M is an exceptionally large private placement for a synthetic biology company, indicating strong institutional confidence. - First sale date over 4 years ago implies this filing may be a late/amended notice; verify if a D/A or earlier filing exists. - Lockheed Martin Ventures presence raises the possibility of defense-related biotech applications, warranting further due diligence. ### Risk Indicators & Flags Red flag: First sale date is 2021-10-12, yet the filing appears new in 2026 — this delay could indicate compliance issues or a belated amendment. No ticker and no public company match; ensure this is not a duplicate or erroneous filing. ### Verification & References Company Sana Biotechnology filed Form D (SEC Accession 0001702600-24-20211) on an unknown date before today, raising $511.4M. First sale date 2021-10-12. Related persons include Lockheed Martin Ventures and Bessemer Venture Partners. Verify at https://www.sec.gov/cgi-bin/browse-edgar?company=Sana%20Biotechnology&type=D&action=getcompany.